Articles related to CARDIOVASCULAR EVENTS

This analysis of a PBC patient’s complex lipid profile underscores the importance of diagnosing the specific types of xanthomas, as they are directly indicative of underlying dyslipidemias, which require tailored therapeutic approaches.

Reevaluating beta-blocker therapy post-myocardial infarction, a recent trial found no significant difference in the composite primary endpoint of death from any cause or new myocardial infarction between patients treated with long-term beta-blockers and those without.

Sexual activity is crucial for both physical and psychological health. Engaging patients in discussions about their sexual health may help identify potential health risks and improve overall well-being.

With stress tests potentially costing the US healthcare system up to $500 million annually and leading to unwarranted procedures, it’s time to reassess their routine use in asymptomatic patients and consider more accurate diagnostic alternatives.

In postmenopausal women, calcium and vitamin D supplementation is a double-edged sword, offering protection against cancer while potentially increasing cardiovascular risk. A nuanced approach to patient consultation is vital to navigate these contrasting outcomes.

GLP-1 agonists are increasingly recognized for their dual benefits in type 2 diabetes management and cardiovascular risk reduction, offering a multifaceted approach to patient care in an expanding global market.